Clinical utility of bone mass measurements in adults: Consensus of an international panel

P. D. Miller, S. L. Bonnick, C. J. Rosen, R. D. Altman, L. V. Avioli, J. Dequeker, D. Felsenberg, H. K. Genant, C. Gennari, K. D. Harper, A. B. Hodsman, M. Kleerekoper, C. A. Mautalen, M. R. McClung, P. J. Meunier, D. A. Nelson, N. F A Peel, L. G. Raisz, Robert R. Recker

Research output: Contribution to journalArticle

84 Citations (Scopus)

Abstract

Low bone mass predicts future fracture risk as well as high cholesterol or high blood pressure can predict the risk of heart disease or stroke. Prevention of the first fracture should be a clinical goal. In patients without fractures, osteopenia and osteoporosis can be diagnosed based on the extent of reduction in bone mass below mean peak bone mass of young healthy individuals. As bone mass decreases, fracture risk increases exponentially. Clinical situations in which an assessment of bone mass and fracture risk affects therapeutic decisions include estrogen deficiency, vertebral abnormalities, radiographic osteopenia, asymptomatic primary hyperparathyroidism, and long-term corticosteroid therapy. Serial measurements can also be used to monitor the effects of osteoporosis treatments. The appropriate technique and skeletal site for bone mass measurements should be chosen based on the patient's circumstances and the precision of measurement. A clinical interpretation can enhance the value of computer-generated bone mass measurement reports and improve decision making.

Original languageEnglish
Pages (from-to)361-372
Number of pages12
JournalSeminars in Arthritis and Rheumatism
Volume25
Issue number6
DOIs
StatePublished - 1996

Fingerprint

Consensus
Bone and Bones
Metabolic Bone Diseases
Osteoporosis
Primary Hyperparathyroidism
Bone Fractures
Heart Diseases
Decision Making
Adrenal Cortex Hormones
Estrogens
Therapeutics
Stroke
Cholesterol
Hypertension

All Science Journal Classification (ASJC) codes

  • Anesthesiology and Pain Medicine
  • Orthopedics and Sports Medicine
  • Rheumatology

Cite this

Clinical utility of bone mass measurements in adults : Consensus of an international panel. / Miller, P. D.; Bonnick, S. L.; Rosen, C. J.; Altman, R. D.; Avioli, L. V.; Dequeker, J.; Felsenberg, D.; Genant, H. K.; Gennari, C.; Harper, K. D.; Hodsman, A. B.; Kleerekoper, M.; Mautalen, C. A.; McClung, M. R.; Meunier, P. J.; Nelson, D. A.; Peel, N. F A; Raisz, L. G.; Recker, Robert R.

In: Seminars in Arthritis and Rheumatism, Vol. 25, No. 6, 1996, p. 361-372.

Research output: Contribution to journalArticle

Miller, PD, Bonnick, SL, Rosen, CJ, Altman, RD, Avioli, LV, Dequeker, J, Felsenberg, D, Genant, HK, Gennari, C, Harper, KD, Hodsman, AB, Kleerekoper, M, Mautalen, CA, McClung, MR, Meunier, PJ, Nelson, DA, Peel, NFA, Raisz, LG & Recker, RR 1996, 'Clinical utility of bone mass measurements in adults: Consensus of an international panel', Seminars in Arthritis and Rheumatism, vol. 25, no. 6, pp. 361-372. https://doi.org/10.1016/S0049-0172(96)80001-1
Miller, P. D. ; Bonnick, S. L. ; Rosen, C. J. ; Altman, R. D. ; Avioli, L. V. ; Dequeker, J. ; Felsenberg, D. ; Genant, H. K. ; Gennari, C. ; Harper, K. D. ; Hodsman, A. B. ; Kleerekoper, M. ; Mautalen, C. A. ; McClung, M. R. ; Meunier, P. J. ; Nelson, D. A. ; Peel, N. F A ; Raisz, L. G. ; Recker, Robert R. / Clinical utility of bone mass measurements in adults : Consensus of an international panel. In: Seminars in Arthritis and Rheumatism. 1996 ; Vol. 25, No. 6. pp. 361-372.
@article{2a093e4801284b26a0d5e48feef329ff,
title = "Clinical utility of bone mass measurements in adults: Consensus of an international panel",
abstract = "Low bone mass predicts future fracture risk as well as high cholesterol or high blood pressure can predict the risk of heart disease or stroke. Prevention of the first fracture should be a clinical goal. In patients without fractures, osteopenia and osteoporosis can be diagnosed based on the extent of reduction in bone mass below mean peak bone mass of young healthy individuals. As bone mass decreases, fracture risk increases exponentially. Clinical situations in which an assessment of bone mass and fracture risk affects therapeutic decisions include estrogen deficiency, vertebral abnormalities, radiographic osteopenia, asymptomatic primary hyperparathyroidism, and long-term corticosteroid therapy. Serial measurements can also be used to monitor the effects of osteoporosis treatments. The appropriate technique and skeletal site for bone mass measurements should be chosen based on the patient's circumstances and the precision of measurement. A clinical interpretation can enhance the value of computer-generated bone mass measurement reports and improve decision making.",
author = "Miller, {P. D.} and Bonnick, {S. L.} and Rosen, {C. J.} and Altman, {R. D.} and Avioli, {L. V.} and J. Dequeker and D. Felsenberg and Genant, {H. K.} and C. Gennari and Harper, {K. D.} and Hodsman, {A. B.} and M. Kleerekoper and Mautalen, {C. A.} and McClung, {M. R.} and Meunier, {P. J.} and Nelson, {D. A.} and Peel, {N. F A} and Raisz, {L. G.} and Recker, {Robert R.}",
year = "1996",
doi = "10.1016/S0049-0172(96)80001-1",
language = "English",
volume = "25",
pages = "361--372",
journal = "Seminars in Arthritis and Rheumatism",
issn = "0049-0172",
publisher = "W.B. Saunders Ltd",
number = "6",

}

TY - JOUR

T1 - Clinical utility of bone mass measurements in adults

T2 - Consensus of an international panel

AU - Miller, P. D.

AU - Bonnick, S. L.

AU - Rosen, C. J.

AU - Altman, R. D.

AU - Avioli, L. V.

AU - Dequeker, J.

AU - Felsenberg, D.

AU - Genant, H. K.

AU - Gennari, C.

AU - Harper, K. D.

AU - Hodsman, A. B.

AU - Kleerekoper, M.

AU - Mautalen, C. A.

AU - McClung, M. R.

AU - Meunier, P. J.

AU - Nelson, D. A.

AU - Peel, N. F A

AU - Raisz, L. G.

AU - Recker, Robert R.

PY - 1996

Y1 - 1996

N2 - Low bone mass predicts future fracture risk as well as high cholesterol or high blood pressure can predict the risk of heart disease or stroke. Prevention of the first fracture should be a clinical goal. In patients without fractures, osteopenia and osteoporosis can be diagnosed based on the extent of reduction in bone mass below mean peak bone mass of young healthy individuals. As bone mass decreases, fracture risk increases exponentially. Clinical situations in which an assessment of bone mass and fracture risk affects therapeutic decisions include estrogen deficiency, vertebral abnormalities, radiographic osteopenia, asymptomatic primary hyperparathyroidism, and long-term corticosteroid therapy. Serial measurements can also be used to monitor the effects of osteoporosis treatments. The appropriate technique and skeletal site for bone mass measurements should be chosen based on the patient's circumstances and the precision of measurement. A clinical interpretation can enhance the value of computer-generated bone mass measurement reports and improve decision making.

AB - Low bone mass predicts future fracture risk as well as high cholesterol or high blood pressure can predict the risk of heart disease or stroke. Prevention of the first fracture should be a clinical goal. In patients without fractures, osteopenia and osteoporosis can be diagnosed based on the extent of reduction in bone mass below mean peak bone mass of young healthy individuals. As bone mass decreases, fracture risk increases exponentially. Clinical situations in which an assessment of bone mass and fracture risk affects therapeutic decisions include estrogen deficiency, vertebral abnormalities, radiographic osteopenia, asymptomatic primary hyperparathyroidism, and long-term corticosteroid therapy. Serial measurements can also be used to monitor the effects of osteoporosis treatments. The appropriate technique and skeletal site for bone mass measurements should be chosen based on the patient's circumstances and the precision of measurement. A clinical interpretation can enhance the value of computer-generated bone mass measurement reports and improve decision making.

UR - http://www.scopus.com/inward/record.url?scp=0029885623&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029885623&partnerID=8YFLogxK

U2 - 10.1016/S0049-0172(96)80001-1

DO - 10.1016/S0049-0172(96)80001-1

M3 - Article

C2 - 8792508

AN - SCOPUS:0029885623

VL - 25

SP - 361

EP - 372

JO - Seminars in Arthritis and Rheumatism

JF - Seminars in Arthritis and Rheumatism

SN - 0049-0172

IS - 6

ER -